News

The partnership will enable CML to increase its market share in the specialized CRO custom bioanalytical testing space, currently serviced by its subsidiary, Hemostasis Reference Laboratory. Expected to

In February 2013, the Agency had granted Fast Track status for ceftolozane/tazobactam in Complicated Intra-Abdominal Infections (cIAI). Cubist Pharmaceuticals Chief Scientific Officer Steven Gilman said that the incentive,

The new venture, Redx Anti-Infectives, will create 119 high value science jobs at the site, establishing a new team to develop drugs combatting resistance to antibiotics and new

Powered by CVS/pharmacy and accessible through Viagra.com, the site offers men with erectile dysfunction (ED) an opportunity to purchase Viagra online (with a valid prescription) from a trusted

Initially, the collaboration will focus on one program, but has the potential to encompass multiple targets. As per the agreement, Concert will receive an upfront payment of more

The funding will move the early-stage research to the next level, to find new medicines for diseases such as TB, malaria, Leishmaniasis and sleeping sickness. Scientists across the

Novartis made a milestone payment related to clinical trial application (CTA/IND) and projected initiation of a Phase 1 trial. MorphoSys chief scientific officer Dr. Marlies Sproll said the

Presented at the 2013 Annual Meeting of the International Anesthesia Research Society (IARS) in San Diego, US, the first study evaluated the use of Exparel administered through Infiltration

The collaborations include a drug discovery project with Western University; a co-development project with Delmar Chemicals; and a drug discovery project with a major global pharmaceutical company. Critical